Ionis Pharmaceuticals, Inc.
MODULATION OF HUNTINGTIN EXPRESSION
Last updated:
Abstract:
Provided herein are methods, compounds, and compositions for reducing expression of huntingtin mRNA and protein in an animal. Such methods, compounds, and compositions are useful to treat, prevent, delay, or ameliorate Huntington's disease, or a symptom thereof.
Status:
Application
Type:
Utility
Filling date:
12 Oct 2020
Issue date:
13 May 2021